CI Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
73.4B
+2.8%
71.4B
+4.5%
68.3B
-5.3%
72.1B
+3.8%
69.5B
Cost of Revenue
67.1B
+3.0%
65.1B
+5.0%
62.0B
-6.1%
66.1B
+4.2%
63.4B
Gross Profit
6.3B
+0.8%
6.3B
-0.1%
6.3B
+3.1%
6.1B
-1.1%
6.1B
Operating Expenses
4.2B
+8.9%
3.9B
-6.2%
4.1B
+1.0%
4.1B
+7.2%
3.8B
R&D
0
0
0
0
0
SG&A
3.6B
+4.1%
3.5B
-6.8%
3.7B
+3.1%
3.6B
+7.3%
3.4B
Operating Income
2.1B
-12.3%
2.4B
+11.5%
2.2B
+7.5%
2.0B
-14.5%
2.3B
EBITDA
3.0B
-2.7%
3.1B
+9.0%
2.8B
+2.9%
2.7B
-10.3%
3.0B
Net Income
1.7B
-9.4%
1.9B
+0.8%
1.9B
+46.1%
1.3B
-35.4%
2.0B
EPS (Basic)
$5.49
-13.0%
$6.31
+0.2%
$6.30
+34.9%
$4.67
-33.5%
$7.02
EPS (Diluted)
$5.47
-13.0%
$6.29
+0.5%
$6.26
+34.6%
$4.65
-33.4%
$6.98
Shares (Diluted)
263.8M
-0.1%
264.0M
-0.0%
264.0M
-0.6%
265.6M
-0.7%
267.5M
The Cigna (CI) — Financials